CYCN - Cyclerion Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue---
Cost of Revenue---
Gross Profit---
Operating Expenses
Research Development85,71678,80350,903
Selling General and Administrative19,22715,11912,651
Non Recurring---
Total Operating Expenses104,94393,92263,554
Operating Income or Loss-104,943-93,922-63,554
Income from Continuing Operations
Total Other Income/Expenses Net-10,309--
Earnings Before Interest and Taxes-104,943-93,922-63,554
Interest Expense---
Income Before Tax-115,252-93,922-63,554
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-115,252-93,922-63,554
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-115,252-93,922-63,554
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-115,252-93,922-63,554